Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022568 (
keratitis
)
5,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acanthamoeba castellanii
is a ubiquitous free-living amoeba. Pathogenic strains are causative agents of
Acanthamoeba
keratitis
and granulomatous amoebic encephalitis. In response to adverse conditions,
A. castellanii
differentiate into cysts, which are metabolically inactive and resistant cells. This process, also named encystment, involves biochemical and genetic modifications that remain largely unknown. This study characterizes the role of the
ACA1_384820
Acanthamoeba
gene during encystment. This gene encodes a
putative N-acetyltransferase
, belonging to the Gcn5-related N-acetyltransferase (GNAT) family. We showed that expression of the
ACA1_384820
gene was down-regulated as early as two hours after induction of encystment in
A. castellanii
. Interestingly, overexpression of the
ACA1_384820
gene affects formation of cysts. Unexpectedly, the search of homologs of
ACA1_384820
in the Eukaryota gene datasets failed, except for some species in the
Acanthamoeba
genus. Bioinformatics analysis suggested a possible lateral acquisition of this gene from prokaryotic cells. This study enabled us to describe a new
Acanthamoeba
gene that is down-regulated during encystment.
...
PMID:Encystment Induces Down-Regulation of an Acetyltransferase-Like Gene in
Acanthamoeba castellanii
. 3235 98